mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.02 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |